Finn Guo: Driving a New Era of Accessible Gene Therapy for Hemophilia in China
Finn Guo, Director of Information Research at Illness Challenge Foundation, shared on LinkedIn:
”From launching the project in March to completing the research report ‘Payment Mechanism and Global Strategies for Innovative Hemophilia Therapies’ in June — officially presented at the International Hemophilia Conference.
We started with patient surveys to truly understand the challenges, drew insights from international best practices, and finally developed practical solution frameworks.
While the scheme is still a long way from real-world implementation, I’m truly excited that the rapid progress in China’s domestic gene therapy for hemophilia — combined with current market pricing — is set to usher China into a new era of accessible gene therapy.
Hope is on the horizon.”
Stay updated with Hemostasis Today.
-
Jun 14, 2026, 10:47Giulia Simini: Honored to Be Presenting My Award-Winning PhD Research at ISTH 2026
-
Jun 14, 2026, 10:42Sahil Gorka: A Step Forward in Optimizing Platelet Transfusion Assessment
-
Jun 14, 2026, 10:32Naveen Sharma: Fortis Hospital Shalimar Bagh Celebrates World Blood Donor Day with a Life-Saving Blood Donation Drive
-
Jun 14, 2026, 10:06François-Xavier Gros: A Memorable EHA 2026 Sets the Stage for Barcelona 2027
-
Jun 14, 2026, 09:26Jack Shuang Hou: Bezuclastinib Demonstrates Disease-Modifying Potential in Advanced Systemic Mastocytosis
-
Jun 14, 2026, 08:46Ruben Mesa: Exploring New Treatment Options for Myelofibrosis-Related Anemia at EHA 2026
-
Jun 14, 2026, 08:32Manuela Spadea: Celebrating Recognition for Pediatric HSCT Research at EHA 2026
-
Jun 14, 2026, 08:17Amber Yates: Honoring the Sickle Cell Community Behind the Rise Up Study
-
Jun 14, 2026, 06:19Sharmila Manian: World Blood Donor Day – Where Generosity Meets Smart Medicine